Chiasma to Report Second Quarter 2020 Results on August 10
Company to host conference call and webcast at 5:00 p.m. ET
Get Alerts CHMA Hot Sheet
Join SI Premium – FREE
NEEDHAM, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial stage biopharmaceutical company, today announced that it will host a conference call and live audio webcast on Monday, August 10, 2020 at 5:00 p.m. Eastern Time to discuss financial results for the quarter ended June 30, 2020 and to provide a business update.
Conference Call Details
Monday, August 10th @ 5pm Eastern Time
| Domestic: | 855-327-6837 |
| International: | 631-891-4304 |
| Conference ID: | 10010555 |
| Webcast: | http://public.viavid.com/index.php?id=141033 |
A live audio webcast of the call may also be accessed under "Events & Presentations" on the News & Investors section of the Company's website, https://ir.chiasma.com/events-presentations. An archived replay of the webcast will be available on the Company’s website approximately two hours after the event. The archived webcast will be available for one year.
About Chiasma
Chiasma is focused on developing and commercializing oral therapies to improve the lives of patients who face challenges associated with their existing treatments for rare and serious chronic diseases. Employing its Transient Permeability Enhancer (TPE®) technology platform, Chiasma seeks to develop oral medications that are currently available only as injections. On June 26, 2020, Chiasma received FDA approval of MYCAPSSA for long-term maintenance therapy in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. MYCAPSSA is the first and only oral somatostatin analog approved by the FDA. Chiasma is headquartered in Needham, MA with a wholly owned subsidiary in Israel. MYCAPSSA, TPE and CHIASMA are registered trademarks of Chiasma. For more information, please visit the company’s website at www.chiasma.com.
Investor Contact:Ashley R. RobinsonLifeSci Advisors, LLC617-775-5956[email protected]
Media Relations:Patrick BurseyLifeSci Communications646-876-4932[email protected]
Source: ChiasmaSerious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- ATTACK SHARK Unveils R86 HE Carbon Fiber Magnetic Switch Gaming Keyboard, Redefining the 75% Competitive Keyboard Experience
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Needham & Company, Earnings, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share